상세 보기
Repression of <i>SLC22A3</i> by the AR-V7/YAP1/TAZ axis in enzalutamide-resistant castration-resistant prostate cancer
- Seo, Eunjeong;
- Jee, Byula;
- Chung, Jae Hoon;
- Song, Wan;
- Sung, Hyun Hwan;
- ... Jeon, Hwang Gyun;
- ... Jeong, Byong Chang;
- ... Seo, Seong Il;
- ... Jeon, Seong Soo;
- ... Kang, Minyong;
- 외 1명
WEB OF SCIENCE
8SCOPUS
8초록
Metastatic castration-resistant prostate cancer (mCRPC) is an aggressive and fatal disease, with most patients succumbing within 1-2 years despite undergoing multiple treatments. Androgen-receptor (AR) inhibitors, including enzalutamide (ENZ), are used for the treatment of mCRPC; however, most patients develop resistance to ENZ. Herein, we propose that the repression of SLC22A3 by AR-V7/YAP1/TAZ conferred ENZ resistance in mCRPC. SLC22A3 expression is specifically downregulated in the ENZ-resistant C4-2B MDVR cells, and when YAP1/TAZ is hyperactivated by AR full-length or AR-V7, these proteins interact with DNMT1 to repress SLC22A3 expression. We observed low SLC22A3 expression and high levels of TAZ or YAP1 in mCRPC patient tissues harbouring AR-V7 and the opposite expression patterns in normal patient tissues. Our findings suggest a mechanism underlying ENZ resistance by providing evidence that the AR-V7/YAP1/TAZ axis represses SLC22A3, which could be a potential treatment target in prostate cancer.
키워드
- 제목
- Repression of <i>SLC22A3</i> by the AR-V7/YAP1/TAZ axis in enzalutamide-resistant castration-resistant prostate cancer
- 저자
- Seo, Eunjeong; Jee, Byula; Chung, Jae Hoon; Song, Wan; Sung, Hyun Hwan; Jeon, Hwang Gyun; Jeong, Byong Chang; Seo, Seong Il; Jeon, Seong Soo; Lee, Hyun Moo; Kang, Minyong
- 발행일
- 2023-03
- 유형
- Article
- 저널명
- FEBS Journal
- 권
- 290
- 호
- 6
- 페이지
- 1645 ~ 1662
- 언어
- ENG
- 출판사
- Blackwell Publishing Inc.
- 발행국가
- 미국
- 분량
- 18 페이지
- ISSN
- E 1742-4658
P 1742-464X